Now's the time.
Help shape a positive future for people with epilepsy.
During the pandemic our laboratories had to close and some of our researchers went back to the NHS to help fight Covid-19. Now they are back to their research again and need your support to make up for lost time. Together, we can recover from the pandemic and continue vital work.
We are Epilepsy Society. The UK’s only charity transforming the lives of people with epilepsy through world-leading research, advocacy and care.
Leading care provider
Our range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Cutting edge research
Epilepsy Society's Chalfont Centre is unique in bringing together intellectual capital to form a powerhouse multidisciplinary team who contribute to a wide ranging spectrum of research.
Epilepsy Support
Our confidential epilepsy helpline and online information give help and support to people who are affected by epilepsy.
Advocacy
We are a voice for people with epilepsy, striving to push epilepsy up the political agenda and bring about change at government level.
Medical services
The Chalfont Centre and our Gowers unit lead the way in the most advanced techniques for the diagnosis and treatment of epilepsy.
Care services
We are the leading charity care provider, where people love to work and live. Our wide range of care is tailored to the needs of each individual, and our professional staff are committed to maximising the life potential of everyone within our care homes.
Campaigns
Our campaigns team lobby government and decision-makers on the issues that matter to people with epilepsy. From safer medicines for pregnant women to the dangers of online harm, and from medicines supply to public transport access, we raise awareness of the daily challenges facing people with epilepsy.
Latest news
Pregabalin - new warnings of increased risks for unborn baby during pregnancy
Women with epilepsy who are taking pregabalin are warned that the medication could increase risk of physical harm for a baby during pregnancy and are advised to consult their doctor. It is important never to stop taking your medication without seeking medical advice first.
Minister promises trolls who target people with epilepsy could face prison
Today (Tuesday 19 April 2022), the Online Safety Bill will have its second reading in the House of Commons. This is a chance for MPs to debate this most important piece of legislation in the internet age. The Epilepsy Society is pleased to have the support of Minister Chris Philp in backing our Zach’s Law campaign to tackle internet trolls who target people with epilepsy in order to trigger seizures.
Adults with epilepsy in social care could be on wrong medication
Researchers at the Epilepsy Society fear that adults in social care with epilepsy and learning disabilities could be receiving the wrong medication or treatment due to a lack of diagnosis.
Epilepsy Society shortlisted for top award
All of us at the Epilepsy Society are delighted to have been shortlisted for a prestigious campaigning award.
Why MP Sarah Green is changing her name to Sarah Purple
It could be something to do with her name, but MP Sarah Green has a propensity for changing the colour of the landscape.
Zach’s Law not in first reading of Online Safety Bill but the campaign continues
The Epilepsy Society is disappointed that Zach’s Law was not included in the first reading of the Online Safety Bill in Parliament yesterday. However, we are hopeful that the new offence to protect people with epilepsy from internet trolls will be included at a later stage in the legislative process.
Our research
Research
The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring (TDM) is an area of clinical chemistry that specialises in measuring medication levels (concentrations) in patients, usually through blood samples but also through saliva samples.
Genomics
Read how we are working to understand the genetic architecture of each individual person's epilepsy through our world leading genomics research programme.
You can call our helpline on 01494 601 400.
Our Helpline is open five days a week, Monday to Friday 9am to 4pm, (Wednesday 9am to 7.30pm).
You can also reach us by email
helpline@epilepsysociety.org.uk.